Table 1:
Covariate | At diagnosis | 5 years | 10 years | 15 years | ||||
---|---|---|---|---|---|---|---|---|
N | % | N | % | N | % | N | % | |
All | 180,434 | 69,469 | 33,066 | 13,722 | ||||
Age | ||||||||
<50 | 24,386 | 13.5% | 12,309 | 17.7% | 7,317 | 22.1% | 3,661 | 26.7% |
50–59 | 52,689 | 29.2% | 22,372 | 32.2% | 11,406 | 34.5% | 5,027 | 37.0% |
60–69 | 55,881 | 31.0% | 21,348 | 30.7% | 9,746 | 29.5% | 3,873 | 28.2% |
70+ | 47,478 | 26.3% | 13,440 | 19.3% | 4,597 | 13.6% | 1,161 | 8.5% |
Sex | ||||||||
Male | 135,416 | 75.1% | 51,986 | 74.8% | 24,503 | 74.1% | 9,964 | 72.6% |
Female | 45,018 | 24.9% | 17,483 | 25.2% | 8,563 | 25.9% | 3,758 | 27.4% |
Race | ||||||||
White | 150,160 | 83.2% | 59,845 | 86.1% | 28,565 | 86.4% | 11,870 | 86.5% |
Black | 21,563 | 12.0% | 6,263 | 9.0% | 2,818 | 8.5% | 1,107 | 8.1% |
Other/unknown | 8,711 | 4.8% | 3,361 | 4.8% | 1,683 | 5.1% | 745 | 5.4% |
Anatomical site | ||||||||
Oropharynx | 60,859 | 33.7% | 21,579 | 31.1% | 9,110 | 27.6% | 2,943 | 21.4% |
Oral cavity | 48,834 | 27.1% | 18,444 | 26.5% | 8,592 | 26.0% | 3,881 | 28.3% |
Hypopharynx & larynx | 70,741 | 39.2% | 29,446 | 42.4% | 15,004 | 45.4% | 6,898 | 50.3% |
Tumor stage | ||||||||
Localized | 47,790 | 26.5% | 27,098 | 39.0% | 15,829 | 47.9% | 7,854 | 57.2% |
Regional | 80,653 | 44.7% | 28,422 | 40.9% | 13,237 | 40.0% | 4,853 | 35.4% |
Distant | 19,212 | 10.6% | 3,356 | 4.8% | 1,230 | 3.7% | 524 | 3.8% |
Unstaged | 32,779 | 18.2% | 10,593 | 15.2% | 2,770 | 8.4% | 599 | 4.4% |
Year of diagnosis | ||||||||
1973–1984 | 24,863 | 13.8% | 10,998 | 15.8% | 7,093 | 21.5% | 4,482 | 32.7% |
1985–1999 | 39,461 | 21.9% | 18,504 | 26.6% | 12,042 | 36.4% | 7,840 | 57.1% |
2000–2015* | 116,110 | 64.4% | 39,967 | 57.5% | 13,931 | 42.1% | 1,400 | 10.2% |
More recent diagnoses have not yet made it to 5, 10, or 15 years after diagnosis.